Routine Cardiac Screening in Sarcoidosis Patients
A legfontosabb adatok
- Ki végzi
- Foundation for Sarcoidosis Research
- Hol
- Albany, Charleston, Chicago, Cincinnati, Cleveland, Denver, Iowa City, Philadelphia és Seattle (Egyesült Államok)Mind a 10 helyszín megnézéseMég 2 másik országban, 2 helyszínen
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 1000 fő vett részt
- Kezdés
- 2019. ápr. 5.
- Befejezés
- 2024. nov. 1.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A vizsgált kezelések
- Enhanced Screening Protocol for Cardiac Sarcoidosis.
- Routine Screening for Suspected Cardiac Sarcoidosis
- A regiszteradat frissítve
- 2025. január 14.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 7 feltétel megnézéseKevesebb
Ki vehet részt
- Diagnosis of sarcoidosis as per The American Thoracic Society guidelines
- First visit to the enrolling center
- Intent to continue care at the enrolling center at least annually
Ki nem vehet részt
- Referred to the enrolling center to evaluate for suspected cardiac sarcoidosis
- Pre-existing high suspicion for cardiac sarcoidosis, defined as having had cardiac MRI or cardiac PET scan, even if it was ordered by other institutions
- Severe sarcoidosis or other disease conferring a high likelihood of death or transplant within the next year
- Unwilling or unable to undergo echocardiography and ambulatory ECG
Helyszínek itt: Egyesült Államok
Még 2 másik országban, 2 helyszínen
- Albany Medical CenterAlbany, Egyesült Államok
- Medical University of South CarolinaCharleston, Egyesült Államok
- Northwestern University MedicineChicago, Egyesült Államok
- University of Illinois Medical Center at ChicagoChicago, Egyesült Államok
- University of Cincinnati Medical CenterCincinnati, Egyesült Államok
- Cleveland ClinicCleveland, Egyesült Államok
- National Jewish HealthDenver, Egyesült Államok
- University of Iowa HospitalIowa City, Egyesült Államok
- Penn MedicinePhiladelphia, Egyesült Államok
- University of Washington Medical CenterSeattle, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This protocol is an unblended randomized screening trial will have consecutive patients with no suggestion of cardiac sarcoidosis according to usual screening enroll in an enhanced screening protocol. The routine clinical care is to gather patient's history of symptoms and under go an ECG. If a patient has an abnormal results in standard screening, they typically have further evaluations as part of their routine medical care. These tests might include an echocardiogram, ambulatory ECG, and advanced cardiac imaging (MRI, PET scan as per local practice). A patient that has normal results on standard screening will be randomly assigned to enhanced screening at each center. Half the patients will be randomized to usual follow-up (annual symptom assessment and ECG) and the other half will be assigned to the enhanced screening (echocardiogram and ambulatory ECG at enrollment and at 24 months).
A teljes eredeti leírásKevesebb
The investigators hypothesize that screening using conventional history, physical and ECG in the general sarcoidosis population, followed by appropriate advanced imaging testing, will result in the identification of a higher percentage of ascertained cardiac sarcoidosis than has been reported historically (2-5%). The investigators hypothesize that routine use of echocardiogram with strain and ambulatory ECG will identify additional patients who will have advanced imaging abnormalities or who meet criteria for cardiac sarcoidosis. The investigators further hypothesize that re-screening patients after 24 months with repeat echocardiogram and ambulatory ECG will identify additional patients with suspicion for cardiac sarcoidosis who had no abnormalities on the standard screening tests.
A vizsgálat 2 csoportja
- Enhanced Screening Protocol For Cardiac Sarcoidosis
Arm will be randomly assigned to undergo enhanced screening methods (ambulatory ECG and echocardiogram) at month 0 and month 24, as well as a phone call/chart review at month 12.
- Routine Screening for Suspected Cardiac Sarcoidosis
Arm will be randomly assigned for the routine standard of care/no intervention with enhanced screening methods. They will be offered the EKG and symptom check at months 0 and 24, as well as a phone call/chart review at month 12.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Randomized Screening Trial for Cardiac Sarcoidosis (CS) in Patients Seen During Routine Clinical Care Who Have Not Been Clinically Suspected to Have (CS), Comparing the Addition of Echocardiogram and Ambulatory ECG to Standard of Care.
- A regiszteradat frissítve
- 2025. január 14.